Targeting of CD38 by the tumor suppressor miR-26a serves as a novel potential therapeutic agent in multiple myeloma
| Image |  |
|---|---|
| Description | scientific article published on 19 March 2020 |
| Author/s | |
| Publication date | March 19, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |